12.11
12-3月-25 16:45:01
15 分の遅延
株式
+0.67
+5.86%
本日の幅
11.47 - 12.38
ISIN
N/A
ソース
NASDAQ
Replimune to Present at the 39th Annual J.P. Morgan Healthcare Conference
06 1 2021 08:00:01 提供 Nasdaq GlobeNewswire
Replimune Announces First Patient Dosed with RP3 in a Phase 1 Clinical Trial in Patients with Advanced Solid Tumors
05 1 2021 08:00:02 提供 Nasdaq GlobeNewswire